GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Discussion] can we stop arguing about telehealth until somebody posts a number — 46 comments in the full submission. View in context.
2.7k
c/compounding·submitted 1 year ago by u/lina_ndiaye

[Discussion] can we stop arguing about telehealth until somebody posts a number

Discussionbranch of 6 comments

Trying to settle this properly because the thread from last year went in circles. The claim: state board matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 17 months without either producing anything. What would actually settle it is 17 people measuring the…

Read the full submission and all 46 comments →

This branch

6 comments, started 1 year ago
u/burned_once_twice-33 points·1 year ago

the shortage list is temporary, it ends and compounding becomes illegal again

replysharereportpermalink
u/lina_ndiayeOP1 point·1 year ago

Moved states and the compounding landscape changed completely. Different rules, different pharmacies, different costs.

replysharereportpermalink
u/runa_grimaldi1 point·1 year ago

Moved states and the compounding landscape changed completely.

Adding to this: 503B is doing more work than the comment implies.

replysharereportpermalink
u/lipid_panel_larrybloodwork1 point·1 year ago

telehealth costs 503A plus compounding markup, total varies

replysharereportpermalink
u/blunt_coldbox_notes1 point·1 year ago

the 503A/503B distinction is load-bearing, do not blur it

replysharereportpermalink
[removed]1 point·1 year ago

[removed by moderator]

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.comSponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →